Pharmacogenomics and artificial intelligence in cardiovascular disease: emerging tools for precision medicine
Pharmacogenomics. 2026 Sep 14:1-13. doi: 10.1080/14622416.2026.2732154. Online ahead of print.ABSTRACTCardiovascular diseases (CVD) remain a predominant cause of mortality and morbidity globally. Conventional therapy methods may be constrained by their inadequate acknowledgment of individual genetic

